Medical News

RSS

Anti-PD-1 treatment reduces tumor size and post-surgical relapse of lung cancer

A drug given to early stage lung cancer patients before they undergo surgery showed major tumor responses in the removed tumor and an increase in anti-tumor T-cells that remained after the tumor was removed, which resulted in fewer relapse cases in the patients.

16 Apr 2018

Single FMT enema produces sustained and significant improvements in cognitive function

A single treatment using an optimized, targeted form of faecal microbiota transplantation (FMT) produces sustained clinical and cognitive improvements, according to the results of a long-term follow-up of patients with liver cirrhosis and hepatic encephalopathy (HE) who had participated in a short-term study.

16 Apr 2018

Artificial antimicrobial peptides may help fight against drug-resistant bacteria

During the past several years, many strains of bacteria have become resistant to existing antibiotics, and very few new drugs have been added to the antibiotic arsenal.

16 Apr 2018

New tool developed to protect women from HIV infection

Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection.

16 Apr 2018

Finding ways to reverse obesity’s lingering, pro-cancer effects

Like exposure to too much sun and drinking alcohol, obesity is a risk factor for cancer. Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center are working to be a part of the solution -- they want to find ways to reverse obesity-linked biological changes in the body that are associated with cancer growth.

16 Apr 2018

AASM position statement: Medical cannabis not be used for treatment of sleep apnea

Medical cannabis and synthetic marijuana extracts should not be used for the treatment of obstructive sleep apnea, according to a position statement from the American Academy of Sleep Medicine.

16 Apr 2018

Intranasal formulation of ketamine shows promise in rapid treatment of depression, suicidality

A nasal spray formulation of ketamine shows promise in the rapid treatment of symptoms of major depression and suicidal thoughts, according to a new study published online today in The American Journal of Psychiatry.

16 Apr 2018

Study reveals increased risks for Alzheimer's, suicide among youth in polluted cities

A University of Montana researcher and her collaborators have published a new study that reveals increased risks for Alzheimer's and suicide among children and young adults living in polluted megacities.

16 Apr 2018

SYGNIS AG extends manufacturing capability for Lightning-Link technology

SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced it has extended the manufacturing capability for its Lightning-Link technology, currently marketed under the Expedeon brand, to support scalability and bulk production of antibodies.

16 Apr 2018

SYGNIS AG introduces new TruePrime apoptotic cell free DNA amplification kit

SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced the launch of its TruePrime apoptotic cell free DNA amplification kit, under the Expedeon brand.

16 Apr 2018

SYGNIS AG launches new Universal Lateral Flow Assay kit and files patent application

SYGNIS AG today announced the launch of its Universal Lateral Flow Assay kit, the latest addition to its expanding range of lateral flow assay products and services which are being commercialized under the Expedeon brand name.

16 Apr 2018

Expedeon relocates to Cambridge as part of integration into SYGNIS Group

SYGNIS AG today announced the completion of the relocation of its subsidiary company, Expedeon, into the Company’s existing facilities in Cambridge, UK.

16 Apr 2018

SYGNIS AG acquires bioconjugation specialist Expedeon

Expedeon, a specialist provider of bioconjugation products and services, has announced it has been fully acquired by Sygnis AG, for EUR 8 million in cash and 3.5 million in shares.

16 Apr 2018

Single foodborne outbreak can have large ramifications for restaurants

A single foodborne outbreak could cost a restaurant millions of dollars in lost revenue, fines, lawsuits, legal fees, insurance premium increases, inspection costs and staff retraining, a new study from researchers at the Johns Hopkins Bloomberg School of Public Health suggests.

16 Apr 2018

Tiny layer of graphene flakes becomes deadly weapon against bacteria on implants

A tiny layer of graphene flakes becomes a deadly weapon and kills bacteria, stopping infections during procedures such as implant surgery. This is the findings of new research from Chalmers University of Technology, Sweden, recently published in the scientific journal Advanced Materials Interfaces.

16 Apr 2018

Cancer Australia launches new framework to improve outcomes for lung cancer patients

In an Australian first, Cancer Australia today launched a Framework to improve the outcomes and experiences of people affected by lung cancer – the leading cause of cancer death in Australia.

16 Apr 2018

Brief elevation of airborne particulate matter linked to respiratory infection in children

Even the briefest increase in airborne fine particulate matter PM2.5, pollution-causing particles that are about 3 percent of the diameter of human hair, is associated with the development of acute lower respiratory infection (ALRI) in young children, according to newly published research.

16 Apr 2018

Medical News

Anti-PD-1 treatment reduces tumor size and post-surgical relapse of lung cancer

Single FMT enema produces sustained and significant improvements in cognitive function

Artificial antimicrobial peptides may help fight against drug-resistant bacteria

New tool developed to protect women from HIV infection

Finding ways to reverse obesity’s lingering, pro-cancer effects

AASM position statement: Medical cannabis not be used for treatment of sleep apnea

Intranasal formulation of ketamine shows promise in rapid treatment of depression, suicidality

Study reveals increased risks for Alzheimer's, suicide among youth in polluted cities

SYGNIS AG extends manufacturing capability for Lightning-Link technology

SYGNIS AG introduces new TruePrime apoptotic cell free DNA amplification kit

SYGNIS AG launches new Universal Lateral Flow Assay kit and files patent application

Expedeon relocates to Cambridge as part of integration into SYGNIS Group

SYGNIS AG acquires bioconjugation specialist Expedeon

Single foodborne outbreak can have large ramifications for restaurants

Tiny layer of graphene flakes becomes deadly weapon against bacteria on implants

Cancer Australia launches new framework to improve outcomes for lung cancer patients

Brief elevation of airborne particulate matter linked to respiratory infection in children

Study: Yoga and mindfulness may help elementary school students manage stress, anxiety

The memory area of the brain may also yield vital clues about mental health illnesses

Painkiller use during pregnancy could affect unborn child's fertility in later life

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News